Primary care practitioners should be aware of 3 new FDA approvals that may be useful when treating patients with meningitis B, hemophilia A, and non-valvular atrial fibrillation.
The FDA granted fast track priority review and approved two new treatments for idiopathic pulmonary fibrosis ahead of originally intended approval dates.
Primary care practitioners should be aware of new FDA approvals that may be useful when treating patients with COPD, melanoma, and Crohn's disease.
